Galapagos | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
argenx SE 4.26B 3.84B 2024-09
AstraZeneca USD 40.87B 66M 2024-12
Biogen USD 16.72B 357.1M 2024-12
Genmab DKK 36.7B 4.78B 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
GRIFOLS EUR 5.88B 533.83M 2024-12
Hikma Pharmaceutical USD 2.29B 88M 2024-06
Incyte USD 3.45B 276.41M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 73B 1.36B 2024-06
UCB EUR 10.03B 1.08B 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Galapagos Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.